Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 67.717 |
|
|||||
| News | - |
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| TRACON Pharmaceuticals Inc | TCON | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,04 | -3,10% | 1,25 | 01:51:20 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 1,27 | 1,21 | 1,33 | 1,23 | 1,29 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen |
|---|---|---|---|---|
| 711 | 67.717 | US$ 1,26 | US$ 85.237 | - |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:25:24 | 46 | US$ 1,26 | USD |
Finanzwerte TCON
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 58,25M | 45,50M | - | 12,05M | -3,59M | -0,08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News TRACON Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 12.6.2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.5.2024 | 23:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 14.5.2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.5.2024 | 23:00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 13.5.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.3.2024 | 23:03 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 05.3.2024 | 23:00 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 28.2.2024 | 22:02 | GlobeNewswire Inc. | TRACON to Report Fourth Quarter and Year-End 2023 Financial.. |
| 14.2.2024 | 22:31 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 09.2.2024 | 22:05 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 19.12.2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08.12.2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum TRACON Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
TCON Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
